Velan Capital Investment Management’s Tenax Therapeutics TENX Stock Holding History

Velan Capital Investment Management’s Portfolio TENX Stock Details TENX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.33M	Buy	583,333 +500,000	+600%	+$6.76M	5.84%	6
2025 Q4	$1.02M	Hold	83,333	–	–	0.59%	25
2025 Q3	$634K	Hold	83,333	–	–	0.6%	25
2025 Q2	$480K	Hold	83,333	–	–	0.47%	26
2025 Q1	$546K	Hold	83,333	–	–	0.56%	26
2024 Q4	$516K	Hold	83,333	–	–	0.45%	20
2024 Q3	$288K	Buy	+83,333	New	+$302K	0.27%	18

Other funds holding TENX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Velan Capital Investment Management's TENX Position: Q1 2026 in Review

Velan Capital Investment Management increased its Tenax Therapeutics (TENX) stake by 600% in Q1 2026, buying an estimated $6.76M and bringing the position to 583,333 shares worth $9.33M. The position accounts for 5.84% of the portfolio, ranked #6.

Velan Capital Investment Management first reported a position in TENX in Q3 2024 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

Velan Capital Investment Management held 583,333 shares of Tenax Therapeutics worth $9.33M as of Q1 2026.
Velan Capital Investment Management bought 500,000 Tenax Therapeutics shares in Q1 2026, an estimated $6.76M.
Tenax Therapeutics made up 5.84% of Velan Capital Investment Management's portfolio in Q1 2026, its #6 holding.
Velan Capital Investment Management first reported a position in Tenax Therapeutics in Q3 2024 and has held it in 7 quarters since.
80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.